QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

AGL

QT81Agilon Health, Inc.
NYSE·Healthcare·Medical - Care Facilities·USA
Latest market price
113.80
+9.13+8.72%
OverviewShort InterestFilings
AGLQT81Agilon Health, Inc.·NYSE
OverviewShort InterestFilings
113.80+8.72%
TA
Loading chart...
Screen all →
HCA-3.35%$375.17THC-3.32%$172.57DVA-1.27%$207.91SOLV+1.17%$75.43FMS+0.08%$23.59EHC+0.14%$98.03ENSG-1.41%$153.65UHS-0.06%$141.17
Snapshot
Index-P/E-EPS (ttm)-22.70
Insider Own-
Shs Outstand16.68M
Perf Week-2.03%
Market Cap1.75BForward P/E-EPS next Y-0.99Insider Trans3.00%Shs Float-Perf Month29.02%
Enterprise Value1.64BPEG0.10EPS next Q0.06Inst Own-Short Float-Perf Quarter864.41%
Income-375452754.00P/S0.30EPS this Y87.48%Inst Trans-Short Ratio-Perf Half Y581.03%
Sales5.82BP/B9.58EPS next Y65.08%ROA-24.82%Short Interest-Perf YTD560.86%
Book/sh10.85P/C-EPS next 5Y-ROE-146.01%52W High118.25 -3.76%Perf Year116.76%
Cash/sh13.85P/FCF-EPS past 3/5Y-ROIC-158.86%52W Low7.48 1421.39%Perf 3Y-
Dividend Est.-EV/EBITDA-4.81Sales past 3/5Y35.44% 37.25%Gross Margin-2.74%Volatility6.53% 6.64%Perf 5Y-
Dividend TTM-EV/Sales0.28EPS Y/Y TTM35.11%Oper. Margin-6.75%ATR (14)9.32Perf 10Y-
Dividend Ex-DateNov 16, 2011Quick Ratio1.04Sales Y/Y TTM-3.99%Profit Margin-6.42%RSI (14)69.15Recom2.71
Dividend Gr. 3/5Y-Current Ratio1.04EPS Q/Q-SMA2016.51%Beta2.91Target Price53.20
Payout0.00%Debt/Eq0.18Sales Q/Q-7.37%SMA5077.23%Rel Volume1.00Prev Close104.67
Employees1,076LT Debt/Eq0.14EarningsAug 03SMA200274.64%Avg Volume438.87KPrice113.80
IPO DateApr 15, 2021Option/ShortYes / YesEPS/Sales Surpr.59.29% 2.90%Net Debt/EBITDA0.31Volume439,899Change8.72%
Analyst Ratings
DateActionAnalystRatingTarget
May-26-26UpgradeBarclaysUnderweight → Equal Weight$81
May-08-26ReiteratedWells FargoOverweight$1.50 → $72
May-07-26UpgradeJefferiesHold → Buy$1.10 → $48
May-07-26UpgradeDeutsche BankHold → Buy$33 → $49
May-04-26DowngradeJP MorganNeutral → Underweight
Apr-09-26ReiteratedDeutsche BankHold$2.00 → $33
Apr-08-26ReiteratedEvercore ISI$16
Oct-07-25ReiteratedWells FargoOverweight$1.50
Aug-20-25DowngradeBernsteinOutperform → Market Perform
Aug-15-25ReiteratedJefferiesHold$1.10
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
Total Revenue5,8195,9336,061
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A5,9796,1216,056
Gross Profit-160-1895
Selling, General and Administrative Excl. Other226239269
Research and Development
000
Other Operating Expense8-728
Operating Income-393-421-292
Interest Expense476
Unusual Expense
———
Non-Operating Income (Expense)-24-24-49
Net Income Before Taxes-373-404-249
Income Taxes111
Consolidated Net Income-373-405-260
Net Income From Continuing Operations-373-405-250
Net Income-373-405-260
EPS (Recurring)-22.70-24.50-15.75
EPS (Basic, Before Extraordinaries)-22.70-24.50-15.75
EPS (Diluted)-22.70-24.50-15.75
EBITDA-340-369-218
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio0.330.05—
Gross Margin-2.75-3.190.08
Operating Margin-6.75-7.10-4.82
Net Margin-6.41-6.83-4.29
Shares Outstanding171716
Market Capitalization1,935293—
Operating Lease Expense
———
Insider Trading Volume
$121.41$107.97$94.53$81.10$67.66● Close Price0.00K75.26K150.53K225.79K301.05KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Shaker BenjaminChief Markets OfficerMar 02 '26Buy0.60500,000301,0501,367,674Mar 03 12:00 AM
Wulf John WilliamDirectorNov 12 '25Buy0.6381,00050,941365,857Jan 30 12:00 AM
Schwaneke Jeffrey A.Chief Financial OfficerNov 29 '23Buy11.2244,600500,41231,931Apr 03 12:00 AM
Shaker BenjaminChief Markets OfficerMar 14 '25Buy0.0011,7860461,201Mar 18 12:00 AM
Venkatachaliah GirishChief Technology OfficerMar 14 '25Buy0.009,4290158,431Mar 18 12:00 AM
Sell StevenCEO & PresidentMar 14 '25Buy0.0042,4260370,873Mar 18 12:00 AM
McLoughlin KarenDirectorDec 13 '24Buy2.2025,00055,08573,166Dec 13 12:00 AM
Battaglia SilvanaDirectorDec 11 '24Buy2.0125,06250,26966,144Dec 13 12:00 AM
MCKENZIE DIANADirectorDec 09 '24Buy2.207,50016,48958,819Dec 11 12:00 AM
Wulf John WilliamDirectorDec 05 '24Buy2.1845,00098,145206,133Dec 11 12:00 AM
MCKENZIE DIANADirectorNov 25 '24Buy2.2812,50028,47451,319Dec 11 12:00 AM
Sell StevenCEO & PresidentSep 12 '24Buy3.3620,00067,18867,590Sep 16 12:00 AM
Desai VeeralChief Strategy & Dev. OfficerMar 14 '24Buy0.0011,9560311,541Mar 18 12:00 AM
Kornitzer BenjaminChief Med. & Quality OfficerMar 14 '24Buy0.005,434063,941Mar 18 12:00 AM
Venkatachaliah GirishChief Technology OfficerMar 14 '24Buy0.005,434041,833Mar 18 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR